Table 3

Prevalence of Symptoms, Blood Marker Positivity, and FCal Positivity by Final Diagnosis

DiagnosisNo. (%)Symptom Positive,a No.Blood Marker Positive,b No.FCal >50 μg/g, No.Range of FCal, μg/g
Primary care cohort
Functional gastrointestinal disorder108 (95)2491220–257
Gastroenteritisc5 (45)00120–88
Declined endoscopy1 (1)10
Referred cohort
IBD
 Crohn disease7 (8)776152–2,823
 Ulcerative colitis8 (9)74853–916
 IBD unclassified2 (2)21279–778
Non-IBD
 Functional gastrointestinal disorder66 (73)40121020–185
 Gastroenteritisc3 (3)10020–45
 Reflux esophagitis1 (1)00022
 Celiac disease1 (1)10020
 Solitary rectal ulcer1 (1)101299
  • FCal = fecal calprotectin; IBD = inflammatory bowel disease.

  • a Presence of 1 or more of the following: growth failure, involuntary weight loss, rectal blood loss, extraintestinal symptoms, perianal lesions, family history of IBD.

  • b Hemoglobin (4–12 years old <7.1 mmol/L; 12–18 years old: boys <8.1 mmol/L, girls <7.4 mmol/L), C-reactive protein (>10 mg/L), erythrocyte sedimentation rate (>20 mm/h), platelet count(>450 × 109/L).

  • c Due to Salmonella enterica (0 cases included by primary care physician; 2 cases included by pediatrician), Shiga toxin–producing Escherichia coli (STEC) (1 and 0), and Giardia lamblia (4 and 1).

  • Note: One child declined endoscopy and evaluation of red flags at 12 months’ follow-up, so the diagnosis was unknown. Nine children without IBD, including 1 child with a solitary rectal ulcer, underwent upper and lower endoscopy, including ileal intubation. The remaining 3 children did not undergo complete endoscopic evaluation for various reasons: the colonoscopy was prematurely terminated because of mucosal bleeding in 1 child with a functional gastrointestinal disorder, but was not repeated because symptoms subsided; 1 child with a functional gastrointestinal disorder underwent colonoscopy only, but not esophagogastroduodenoscopy; and 1 child received a diagnosis of celiac disease by esophagogastroduodenoscopy only.